Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer

The development of targeted therapies increases treatment options for metastatic castration resistant prostate cancer (mCRPC) patients. There is a need for strong predictive and prognostic signatures to guide physicians in treating mCRPC patients. In this review we unravel the possible actionability...

Descripción completa

Detalles Bibliográficos
Autores principales: Devlies, Wout, Eckstein, Markus, Cimadamore, Alessia, Devos, Gaëtan, Moris, Lisa, Van den Broeck, Thomas, Montironi, Rodolfo, Joniau, Steven, Claessens, Frank, Gevaert, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698403/
https://www.ncbi.nlm.nih.gov/pubmed/33212909
http://dx.doi.org/10.3390/cells9112494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698403/
https://www.ncbi.nlm.nih.gov/pubmed/33212909
http://dx.doi.org/10.3390/cells9112494

Ejemplares similares